Thymosin-Alpha is a small protein peptide produced in thymic tissue. The thymus is a gland beneath the breastbone which produces ‘fighting T-cells’ and restores immune function, especially in viral infections. Thymosin-Alpha has been shown to have a pleiotropic mechanism of action and it affects multiple immune cells that are involved in immune suppression. Studies have demonstrated improvements in immune system cells and the demonstrated potential of TA for the treatment of a range of diseases and age or disease-related immune suppression. It is given to help control inflammation associated with chronic diseases, and other autoimmune diseases which can cause weakened body systems and fatigue.